Home / Inspections / 1210497

FDA Inspection 1210497 — Carter BloodCare - Preston Valley

Carter BloodCare - Preston Valley — FEI 3005168208

The FDA completed an inspection of Carter BloodCare - Preston Valley on July 7, 2023 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 7, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dallas, TX (United States)

Facility

Other inspections at this facility

  • 1097091 (NAI Fri Jul 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 997058 (NAI Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 852896 (NAI Thu Oct 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 749027 (NAI Fri Oct 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 545985 (NAI Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources